The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Price Ben Gil since year 2005.
The trader's CIK number is 1417915.
At the time of the last reporting, Price Ben Gil was the Director of Rexahn Pharmaceuticals, Inc. .
(stock ticker symbol RNN).
See this page for all insider trading activities at Rexahn Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-01-29||RNN||Rexahn Pharmaceuticals, Inc.||Buy||15,000||.61||9,135|
|2016-03-14||SRPT||Sarepta Therapeutics, Inc.||Buy||4,500||16.70||75,145|
|2013-08-19||SRPT||Sarepta Therapeutics, Inc.||Buy||500||31.18||15,587|
|2012-03-14||AVII||Sarepta Therapeutics, Inc.||Buy||30,000||1.29||38,850|
|2011-04-06||AVII||Sarepta Therapeutics, Inc.||Buy||20,000||1.50||30,000|
|2010-08-13||AVII||Sarepta Therapeutics, Inc.||Buy||4,000||1.93||7,720|
|2010-06-11||AVII||Sarepta Therapeutics, Inc.||Buy||7,000||1.44||10,080|
|2010-05-13||AVII||Sarepta Therapeutics, Inc.||Buy||40,000||1.36||54,400|
|2009-03-16||AVII||Sarepta Therapeutics, Inc.||Buy||20,400||.67||13,688|
|2009-03-13||AVII||Sarepta Therapeutics, Inc.||Buy||30,000||.65||19,350|
|2008-08-15||AVII||Sarepta Therapeutics, Inc.||Buy||6,582||1.22||8,030|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Price Ben Gil (Director of Rexahn Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.